Steris STE
NYSE STE
$216.21 -2.23 (-1.02%)
As of: Sep 9, 2026 · 1:00 PM EDT

Steris (STE) Non-Current Deferred Tax Liability (2018 - 2026)

Steris (STE) posted Non-Current Deferred Tax Liability of $390.8 million for Q2 2026, little changed on a QoQ basis from $390.7 million in Q1 2026, and down 5.01% year-over-year from $411.4 million in Q2 2025.

Analysis

Steris (STE) Non-Current Deferred Tax Liability (2018 - 2026) Analysis & Trends

Steris has reported Non-Current Deferred Tax Liability for 9 years, with the latest figure at $390.8 million in Q2 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 5.01% year-over-year to $390.8 million in Q2 2026; TTM through Jun 2026 was $390.8 million, a 5.01% decrease from a year earlier, with the FY2026 full-year figure at $390.7 million, down 3.22% from the prior year.
  • Non-Current Deferred Tax Liability was $390.8 million for Q2 2026 at Steris, roughly flat from $390.7 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $790.8 million in Q2 2022, with the low at $390.7 million in Q1 2026.
  • Average Non-Current Deferred Tax Liability over 5 years is $541.7 million, with a median of $471.2 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2024: Non-Current Deferred Tax Liability jumped 229.57% in 2022, then retreated 27.04% in 2024.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $724.6 million in 2022, then declined by 14.29% to $621.1 million in 2023, then declined by 27.04% to $453.1 million in 2024, then decreased by 8.52% to $414.5 million in 2025, then declined by 5.72% to $390.8 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $390.8 million (Q2 2026), $390.7 million (Q1 2026), and $414.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 184.79 Bn 179.19 Bn 7.27 Bn
2 Intuitive Surgical 124.38 Bn 119.16 Bn 1.96 Bn
3 Medtronic 118.45 Bn 109.63 Bn 6.34 Bn
4 Stryker 105.32 Bn 101.84 Bn 4.50 Bn
5 Boston Scientific 66.71 Bn 66.17 Bn 3.85 Bn
6 Edwards Lifesciences 49.81 Bn 45.56 Bn 1.35 Bn
7 Alcon 34.03 Bn 32.58 Bn 1.68 Bn
8 Dexcom 32.35 Bn 30.40 Bn 830.00 Mn
9 Steris 21.17 Bn 20.68 Bn 684.20 Mn
10 Zimmer Biomet Holdings 18.27 Bn 17.86 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 390.80 Mn
Mar 31, 2026 390.70 Mn
Dec 31, 2025 414.50 Mn
Sep 30, 2025 412.00 Mn
Jun 30, 2025 411.40 Mn
Mar 31, 2025 403.70 Mn
Dec 31, 2024 453.13 Mn
Sep 30, 2024 462.74 Mn
Jun 30, 2024 456.47 Mn
Mar 31, 2024 479.69 Mn
Dec 31, 2023 621.07 Mn
Sep 30, 2023 613.45 Mn
Jun 30, 2023 617.63 Mn
Mar 31, 2023 617.54 Mn
Dec 31, 2022 724.65 Mn
Sep 30, 2022 710.09 Mn
Jun 30, 2022 790.82 Mn
Mar 31, 2022 780.62 Mn
Dec 31, 2021 752.46 Mn
Sep 30, 2021 752.88 Mn